Italfarmaco Sa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ITALFARMACO SA, and what generic alternatives to ITALFARMACO SA drugs are available?
ITALFARMACO SA has one approved drug.
There is one US patent protecting ITALFARMACO SA drugs.
There are twenty-one patent family members on ITALFARMACO SA drugs in twenty-one countries.
Drugs and US Patents for Italfarmaco Sa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Italfarmaco Sa | TIGLUTIK KIT | riluzole | SUSPENSION;ORAL | 209080-001 | Sep 5, 2018 | AB | RX | Yes | Yes | 8,765,150 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Italfarmaco Sa Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Croatia | P20130021 | ⤷ Subscribe |
Hong Kong | 1161985 | ⤷ Subscribe |
Chile | 2011002217 | ⤷ Subscribe |
Peru | 20120649 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.